Protagen, NMI Developing Assays for Autoimmune Diseases, Cancer
March 16, 2012
Protagen, NMI Developing Assays for Autoimmune Diseases, Cancer
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Protagen and NMI Collaborating on Protein Dx for Cancer and Autoimmune Diseases
March 16, 2012 / ProteoMonitor - Protagen Using UNIarray Platform to ID Biomarkers for Use in Lupus Drug Development
August 5, 2011 / ProteoMonitor - SuppreMol to Use Protagen Biomarker Panel
August 2, 2011 / GenomeWeb Daily News - Protagen to ID Protein Biomarkers in Support of Biogen's MS Drug Development Work
April 1, 2011 / ProteoMonitor - Protagen, MicroDiscovery Collaborate on Biomarkers
October 15, 2010 / GenomeWeb Daily News